Barrier Agent is a protective pharmaceutical formulation designed to physically coat and shield inflamed mucosal surfaces, thereby reducing irritation and promoting healing in the context of mucositis treatment.
51
Publications
1.6K
Citations
255
Authors
90
Institutions
Publications per year
2017–2026
11
Variants
Barrier Agent
Parents
Publications
51
1–5 of 51
Authors
255
- JL
2
h-index
- QW
2
h-index
- CG
2
h-index
- EM
2
h-index
- WS
2
h-index
1–5 of 255
Institutions
90
Charité - Universitätsmedizin Berlin
Berlin, Germany
2 h-index
11 publications
325 citations
Starship Children's Health
Auckland, New Zealand
2 h-index
6 publications
99 citations
Istituti di Ricovero e Cura a Carattere Scientifico
Rome, Italy
2 h-index
5 publications
90 citations
Procter & Gamble (United States)
Cincinnati, United States
2 h-index
9 publications
234 citations
State Key Laboratory of Biotherapy
Chengdu, China
2 h-index
18 publications
468 citations
Sichuan University
Chengdu, China
2 h-index
18 publications
468 citations
Icahn School of Medicine at Mount Sinai
New York, United States
2 h-index
12 publications
429 citations
Auckland City Hospital
Auckland, New Zealand
2 h-index
6 publications
99 citations
1–8 of 90
Venues
- Contact Dermatitis
6 publications · 166 citations
6
h-index
- PubMed
Repository · 4 publications · 88 citations
4
h-index
- International Journal of Pharmaceutics
3 publications · 218 citations
3
h-index
- British Journal of Nursing
BJN · 3 publications · 62 citations
3
h-index
- Archives of Dermatology
2 publications · 200 citations
2
h-index
1–5